Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparative Study of Modified Release (MR) Tacrolimus/MMF in de Novo Kidney Transplant Recipients
This study has been completed.
Study NCT00064701   Information provided by Astellas Pharma Inc
First Received: July 10, 2003   Last Updated: May 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Transplantation
Interventions listed in this trial
Tacrolimus Modified Release (MR)
Tacrolimus
cyclosporine microemulsion
mycophenolate mofetil
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
Mycophenolic Acid
More general drug interventions related to this trial
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services